Evidence map›Paper›PMID 35273641›Full record

ArticleFrontiers in genetics2022

Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.

Stalinraja Maruthamuthu, Karan Rajalingam, Navchetan Kaur, Maelig G Morvan, Jair Soto, Nancy Lee, Denice Kong, Zicheng Hu, Kevin Reyes, Dianna Ng and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The Role of Killer Ig-like Receptors in Diseases from A to Z.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The immunogenetics of COVID-19.Immunogenetics · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Stalinraja MaruthamuthuImmunogenetics and Transplantation Laboratory, Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Karan RajalingamCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, United States.
Navchetan KaurBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, United States.
Maelig G MorvanImmunogenetics and Transplantation Laboratory, Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Jair SotoImmunogenetics and Transplantation Laboratory, Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Nancy LeeImmunogenetics and Transplantation Laboratory, Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Denice KongImmunogenetics and Transplantation Laboratory, Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Zicheng HuBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, United States.
Kevin ReyesUCSF-Abbott Viral Diagnostics and Discovery Center, Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States.
Dianna NgDepartment of Pathology, University of California, San Francisco, San Francisco, CA, United States.
Atul J ButteBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, United States.
Charles ChiuUCSF-Abbott Viral Diagnostics and Discovery Center, Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States.
Raja RajalingamImmunogenetics and Transplantation Laboratory, Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
University of California, San Francisco · USAbbott (United States) · USFlorida Atlantic University · USUCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

NIH HHS HHSN316201200036W
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiviral immunityCOVID-19 host geneticsCOVID-19 susceptibilityHLA associationKIR-HLA associationKIR receptorsNK cellsSARS-CoV-2 susceptibility

Identifiers

PMID35273641
PMCPMC8902362
OpenAlexW4212875873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.